News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement

Michael Gamble, Yoh Scientific

Advertisement

Articles by Michael Gamble, Yoh Scientific

i3_t-483068-1408661119294.jpg

Outsource from the Inside

ByChris Hediger, Yoh Scientific,Michael Gamble, Yoh Scientific
January 1st 2008

When it comes to clinical teams, the question of whether or not to outsource brings some untraditional answers

Advertisement

Latest Updated Articles

  • i3_t-483068-1408661119294.jpg
    Outsource from the Inside

    Published: January 1st 2008 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Assessing the Access Landscape

2

Pharma Collaborations Focused on Advancing Antibody-Drug Conjugates and Delivering Treatments for Autoimmune Diseases

3

Roundup: Capital Flows into Pharma with Funding Rounds and Loan Facilities

4

Roundup: Biopharmaceutical Industry Activity Accelerates with Focus on Rare Diseases and Novel Therapies

5

Roundup: Biopharma Funding Rounds Advance Clinical Development of Novel Therapy and Treatment Solutions

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us